Skip to Content
Newsletter Desktop Newsletter Mobile
October 30, 2020

Brock Leonti on the importance of intellectual capital

By Adam Burroughs

Perscribe FIT's Brock Leonti on what it’s like to be a startup during a pandemic, and how funders factor in to the company’s success during turbulent times.

October 2, 2020

Kassel Equity Group's Brett Motherwell on balancing dealmaking opportunity and risk

Kassel Equity Group Managing Partner Brett Motherwell talks dealmaking during the pandemic and the importance of careful deal structures to mitigate M&A risks.

August 7, 2020

Don’t overreact to short-term disruption, says COhatch CEO Matt Davis

COhatch CEO Matt Davis on his company's response to the pandemic and why long-term decisions shouldn’t be made in a crisis.

July 30, 2020

Branch Secures $24 Million Series A

Branch, a technology-driven home and auto insurance company, has closed a $24 million Series A funding round co-led by Greycroft and HSCM Bermuda.

July 9, 2020

AB Bernstein’s Kara Lewis and Heather George on the seller fatigue factor

AB Bernstein's Kara Lewis and Heather George explores the seller mindset and how that might affect deal availability for buyers.

June 12, 2020

ChromoCare’s Hugh Cathey: It’s time for careful, creative thinking

It's a challenging business environment right now, which calls for care and out-of-the-box thinking. Hugh Cathey discusses what he’s seeing in today’s market through the lens of both business owner and investor.

May 26, 2020

Cresco Labs Reaches Deal To Acquire Four Ohio Cannabis Dispensaries

Completion of the transaction is subject to approval by the Ohio Board of Pharmacy. Upon closing, Cresco would have a total of five dispensaries in Ohio – the maximum allowed by the state.

May 15, 2020

Ice Miller’s Michael Jordan and Rob Ouellette: M&A and business in a turbulent market

Are deals dead? Ice Miller Partner Rob Ouellette says “no,” but they have taken on a different look. Ouellette and Ice Miller Managing Partner Michael Jordan share their thoughts on M&A and other issues C-suite executives are dealing with during the COVID-19 crisis.